Molecular oncology Journal

Overview

publication venue for

Corrigendum to "Molecular imaging for personalized cancer care" [Mol. Oncol. 6(2) (2012) 182-195]. 2016
Whole-genome sequencing of cell-free DNA reveals DNA of tumor origin in plasma from patients with colorectal adenomas.. 19. 2025
TRPM4 contributes to cell death in prostate cancer tumor spheroids, and to extravasation and metastasis in a zebrafish xenograft model system.. 19. 2025
Strategies to decrease inequalities in cancer therapeutics, care and prevention: Proceedings on a conference organized by the Pontifical Academy of Sciences and the European Academy of Cancer Sciences, Vatican City, February 23-24, 2023.. 18. 2024
From bedside to portable and wearable: development of a conformable ultrasound patch for deep breast tissue imaging.. 17. 2023
Activation of the EGFR/PI3K/AKT pathway limits the efficacy of trametinib treatment in head and neck cancer.. 17. 2023
Novel TCF4:TCF12 heterodimer inhibits glioblastoma growth.. 18. 2023
The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy. 2022
Genes regulated by DNA methylation are involved in distinct phenotypes during melanoma progression and are prognostic factors for patients. 2022
FcγRIIIa receptor interacts with androgen receptor and PIP5K1α to promote growth and metastasis of prostate cancer.. 16. 2022
hnRNP-A1 binds to the IRES of MELOE-1 antigen to promote its translation in stressed melanoma cells. 2021
Lineage-specific mechanisms and drivers of breast cancer chemoresistance revealed by 3D biomimetic culture.. 16. 2021
The PI3K/mTOR inhibitor Gedatolisib eliminates dormant breast cancer cells in organotypic culture, but fails to prevent metastasis in preclinical settings. 2021
KRAS mutant rectal cancer cells interact with surrounding fibroblasts to deplete the extracellular matrix. 2021
Acquired small cell lung cancer resistance to Chk1 inhibitors involves Wee1 up-regulation.. 15. 2021
RAF dimer inhibition enhances the antitumor activity of MEK inhibitors in K-RAS mutant tumors.. 14. 2020
Inhibition of UBE2L6 attenuates ISGylation and impedes ATRA-induced differentiation of leukemic cells.. 14. 2020
PIM protein kinases regulate the level of the long noncoding RNA H19 to control stem cell gene transcription and modulate tumor growth.. 14. 2020
NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers.. 14. 2020
Genetic analysis of uterine adenosarcomas and phyllodes tumors of the breast.. 11. 2017
Improving fascin inhibitors to block tumor cell migration and metastasis.. 10. 2016
EMT is associated with, but does not drive resistance to ALK inhibitors among EML4-ALK non-small cell lung cancer.. 10. 2015
Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: Repertoire of somatic genetic alterations and clonal relationships.. 10. 2015
Sensitivity of plasma BRAFmutant and NRASmutant cell-free DNA assays to detect metastatic melanoma in patients with low RECIST scores and non-RECIST disease progression.. 10. 2015
Gene expression profiling of lobular carcinoma in situ reveals candidate precursor genes for invasion.. 9. 2014
Serum metabolomic profiles evaluated after surgery may identify patients with oestrogen receptor negative early breast cancer at increased risk of disease recurrence. Results from a retrospective study.. 9. 2014
The immune-related role of BRAF in melanoma.. 9. 2014
Computational analysis of image-based drug profiling predicts synergistic drug combinations: applications in triple-negative breast cancer.. 8. 2014
Slug regulates E-cadherin repression via p19Arf in prostate tumorigenesis.. 8. 2014
Pre-clinical efficacy of PU-H71, a novel HSP90 inhibitor, alone and in combination with bortezomib in Ewing sarcoma.. 8. 2013
Transfection of chimeric anti-CD138 gene enhances natural killer cell activation and killing of multiple myeloma cells.. 8. 2013
The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer.. 7. 2013
Overexpression of SnoN/SkiL, amplified at the 3q26.2 locus, in ovarian cancers: a role in ovarian pathogenesis.. 2. 2008
Metabolic dialogues: regulators of chimeric antigen receptor T cell function in the tumor microenvironment. 2024
Molecular imaging for personalized cancer care. 2012

Identity

ISO Abbreviation

Mol Oncol

Linking ISSN

1574-7891

Electronic International Standard Serial Number (EISSN)

1878-0261